BCM
CELG

Brasada Capital Management’s Celgene Corp CELG Stock Holding History

Brasada Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-400
Closed -$26K – 303
2018
Q4 		$26K Sell
400
-61
-13% -$4.5K 0.01% 204
2018
Q3 		$41K Buy
+461
New +$40.7K 0.01% 214
2018
Q2 		– Sell
-1,100
Closed -$98K – 337
2018
Q1 		$98K Sell
1,100
-6,000
-85% -$576K 0.03% 172
2017
Q4 		$741K Buy
+7,100
New +$801K 0.25% 87

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brasada Capital Management's CELG Position: Q1 2019 in Review

Brasada Capital Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 400 shares — an estimated $26K sold.

Brasada Capital Management first reported a position in CELG in Q4 2017 and held it in 4 quarters. The position peaked at $741K in Q4 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Brasada Capital Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Brasada Capital Management sold 400 Celgene Corp shares in Q1 2019, an estimated $26K.
  • Brasada Capital Management first reported a position in Celgene Corp in Q4 2017 and held it in 4 quarters.
  • Brasada Capital Management's Celgene Corp position peaked at $741K in Q4 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Brasada Capital Management's 13F filing for Q1 2019, filed 6 May 2019.